Unknown NA INTERVENTIONAL 1-arm NCT00645580

Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

Alterations in mRNA and Protein Expression in Human Peripheral Mononuclear Blood Cells (PMC) of Schizophrenia Patients Treated With Fluvoxamine Augmentation of Antipsychotics: Relationship to Clinical Symptoms and Cognitive Function

Sponsor: Sha'ar Menashe Mental Health Center

Conditions Schizophrenia

Interventions Fluvoxamine

Updated 7 times since 2017 Last updated: Feb 18, 2009 Started: Apr 30, 2008 Primary completion: Apr 30, 2009 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Schizophrenia, this trial is ongoing. The trial is conducted by Sha'ar Menashe Mental Health Center and has accumulated 7 data snapshots since 2008. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA
Jun 2018 — Sep 2020 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sha'ar Menashe Mental Health Center

Data source: Sha'ar Menashe Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mobile Post Hefer, Israel